DNAzyme-based therapeutics for cancer treatment.

about

Theranostic DNAzymes.Characterization of deoxyribozymes with site-specific oxidative cleavage activity against DNA obtained by in vitro selection.Frontiers in nucleic acid-based drug research and development.In vitro repair of a defective EGFP transcript and translation into a functional protein.

P2860

Q37738245-FE6E36EF-B597-43EB-8CCE-783179C01251 Q40062697-7A165FD1-610B-4690-8FFC-DCCED6D85718 Q48355482-545D3245-0870-4800-9D5A-2D3E6E1AA7C7 Q50225651-DE027AB5-969B-4C35-ABFF-C54E577462D0

P2860

DNAzyme-based therapeutics for cancer treatment.

Item

http://www.wikidata.org/entity/Q38962770

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

DNAzyme-based therapeutics for cancer treatment.

@en

type

Item

label

DNAzyme-based therapeutics for cancer treatment.

@en

prefLabel

DNAzyme-based therapeutics for cancer treatment.

@en

P1476

DNAzyme-based therapeutics for cancer treatment.

@en

P2093

Lun-Quan Sun

http://www.w3.org/2001/XMLSchema#string

Shujun Fu

http://www.w3.org/2001/XMLSchema#string

P2860

A DNA enzyme that cleaves RNA

A general purpose RNA-cleaving DNA enzyme

Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents

Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy.

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)

A DNA enzyme with Mg(2+)-dependent RNA phosphoesterase activity.

Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.

P304

1701-1707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.15.106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26381244

http://www.w3.org/2001/XMLSchema#string

DNAzyme-based therapeutics for cancer treatment.

about

P2860

P2860

DNAzyme-based therapeutics for cancer treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698